Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01534546 |
Recruitment Status : Unknown
Verified September 2019 by Shen Lin, Peking University.
Recruitment status was: Active, not recruiting
First Posted : February 16, 2012
Last Update Posted : September 17, 2019
|
Sponsor:
Peking University
Collaborator:
Taiho Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Shen Lin, Peking University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Actual Primary Completion Date : | July 2019 |
Estimated Study Completion Date : | September 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):